Baxter Bros Inc Abbott Laboratories Transaction History

Baxter Bros Inc

$762 Million
Q3 2024

A detailed history of Baxter Bros Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Baxter Bros Inc holds 1,927 shares of ABT stock, worth $229,216. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,927

Previous 2,027 4.93%

Holding current value

$229,216

Previous $210,000 4.29%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$100.07 - $118.13 $10,007 - $11,813	-100 Reduced 4.93%	1,927 $219,000
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $98,677 - $108,984	-901 Reduced 30.77%	2,027 $230,000
Q4 2023 May 17, 2024	BUY	$90.19 - $110.4 $81,261 - $99,470	901 Added 44.45%	2,928 $322,000
Q3 2023 May 17, 2024	BUY	$95.53 - $114.62 $86,072 - $103,272	901 Added 44.45%	2,928 $283,000
Q3 2023 Oct 23, 2023	SELL	$95.53 - $114.62 $38,212 - $45,848	-400 Reduced 12.02%	2,928 $283,000
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $5,708 - $6,609	-59 Reduced 1.74%	3,328 $322,000
Q2 2022 Jul 25, 2022	SELL	$102.07 - $123.37 $10,921 - $13,200	-107 Reduced 3.06%	3,387 $368,000
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $37,854 - $46,161	-332 Reduced 8.68%	3,494 $414,000
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $12,060 - $14,196	114 Added 3.07%	3,826 $444,000
Q4 2020 Jan 25, 2021	SELL	$105.0 - $114.42 $131,250 - $143,025	-1,250 Reduced 25.19%	3,712 $406,000
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $18,328 - $22,258	-200 Reduced 3.87%	4,962 $540,000
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $7,810 - $9,996	102 Added 2.02%	5,162 $472,000
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $25,128 - $36,744	400 Added 8.58%	5,060 $399,000
Q4 2019 Jan 10, 2020	SELL	$78.51 - $87.4 $47,734 - $53,139	-608 Reduced 11.54%	4,660 $405,000
Q4 2019 Jan 09, 2020	BUY	$78.51 - $87.4 $24,102 - $26,831	307 Added 6.19%	5,268 $237,000
Q3 2019 Oct 21, 2019	BUY	$81.84 - $88.74 $32,736 - $35,496	400 Added 8.77%	4,961 $415,000
Q4 2018 Jan 22, 2019	SELL	$65.56 - $74.27 $28,977 - $32,827	-442 Reduced 8.83%	4,561 $330,000
Q3 2018 Oct 11, 2018	BUY	$60.81 - $73.36 $2,554 - $3,081	42 Added 0.85%	5,003 $367,000
Q2 2018 Jul 17, 2018	SELL	$57.57 - $63.54 $3,281 - $3,621	-57 Reduced 1.14%	4,961 $303,000
Q1 2018 May 16, 2018	BUY	$56.27 - $63.62 $15,192 - $17,177	270 Added 5.69%	5,018 $301,000
Q4 2017 Feb 01, 2018	SELL	$53.68 - $57.47 $14,654 - $15,689	-273 Reduced 5.44%	4,748 $271,000
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $241,309 - $269,326	5,021	5,021 $268,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.

Account